A Trial Study of SGN-00101 in Treating Pediatric Patients With Recurrent Respiratory Papillomatosis
Status:
Completed
Trial end date:
2004-01-01
Target enrollment:
Participant gender:
Summary
Recurrent Respiratory Papillomatosis (RRP) causes wart-like lesions along the throat area and
can obstruct the airway or become malignant. The cause has been related to specific types of
Human Papillomavirus (HPV). The purpose of the study is to assess the clinical effectiveness
of a trial drug, SGN-00101, in children with RRP and also assess its safety.